Shattuck Labs

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Shattuck Labs and other ETFs, options, and stocks.

About STTK

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms.

CEO

Taylor H. Schreiber

CEOTaylor H. Schreiber

Employees

Employees75

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2016

Founded2016

Employees

Employees75

STTK Key Statistics

Market cap

441.52M

Market cap441.52M

Price-Earnings ratio

-4.54

Price-Earnings ratio-4.54

Dividend yield

—

Dividend yield—

Average volume

332.86K

Average volume332.86K

High today

$9.80

High today$9.80

Low today

$9.23

Low today$9.23

Open price

$9.65

Open price$9.65

Volume

307.18K

Volume307.18K

52 Week high

$11.11

52 Week high$11.11

52 Week low

$1.33

52 Week low$1.33

Shattuck Labs

Why Robinhood?

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. Show more

STTK Key Statistics

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms.